Henry Lau

Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis

Nianhang Chen, Henry Lau, Linghui Kong et al. · The Journal of Clinical Pharmacology · 2007 · 245 citations

Various Degrees, Hemodialysis, Urology +12

Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.

Yasushi Nakagawa, Veronika Abram, Joan H. Parks et al. · Journal of Clinical Investigation · 1985 · 118 citations · Full text

Calcium Oxalate Nephrolithiasis, Renal Pathology, Glycobiology +19

Pharmacokinetics of Pamidronate Disodium in Patients with Cancer with Normal or Impaired Renal Function

James R. Berenson, Lee S. Rosen, Robert Vescio et al. · The Journal of Clinical Pharmacology · 1997 · 104 citations

Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects

Nianhang Chen, Lian Wen, Henry Lau et al. · Cancer Chemotherapy and Pharmacology · 2011 · 82 citations · Full text

Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report

Stacey L. Berg, Mitchell S. Cairo, Heidi V. Russell et al. · Journal of Clinical Oncology · 2010 · 59 citations · Full text